We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts.
Carcinogenesis 1997 Februrary
Even though epidemiological studies have identified arsenic compounds as carcinogenic to humans, they are not mutagenic in bacterial and mammalian test systems. However, they increase the mutagenicity and clastogenicity in combination with other DNA damaging agents and there are indications of inhibition of DNA repair processes. We investigated the effect of arsenic(III) on nucleotide excision repair (NER) after UV irradiation in human fibroblasts in detail by using two repair-proficient and one partly repair-deficient xeroderma pigmentosum group C human fibroblast cell lines. The results show that two steps of NER are affected by arsenite. Most severely, the incision frequency is reduced at concentrations as low as 2.5 microM arsenic(III); at higher, cytotoxic concentrations, the ligation of repair patches is also impaired. Furthermore, our results indicate that both the global genome repair pathway and the transcription-coupled repair pathway are affected by arsenite. Repair inhibition may well explain the potentiation of genotoxic effects by arsenic in combination with other DNA damaging agents and may thus be of high relevance for the carcinogenic action of arsenic compounds.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.Journal of Clinical Medicine 2024 Februrary 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app